Xencor (XNCR) Gains from Investment Securities (2013 - 2026)
Xencor (XNCR) reported Gains from Investment Securities of $3.0 million for Q1 2026, up 6512.77% quarter-over-quarter from -$47000.0 in Q4 2025.
Xencor (XNCR) Gains from Investment Securities (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 13 years of Gains from Investment Securities data on file, last reported at $3.0 million in Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at $3.0 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $10.3 million (up 4793.64% YoY), and the FY2025 annual result was $7.3 million, up 19.87% from the prior year.
- Gains from Investment Securities rose to $3.0 million in Q1 2026 per XNCR's latest filing, from -$47000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $20.6 million in Q1 2024 and troughed at -$220000.0 in Q2 2024.
- A 4-year average of $4.1 million and a median of $1.9 million in 2022 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2022 and 2025: Gains from Investment Securities tumbled 94.91% in 2022, then soared 3281.82% in 2025.
- A 4-year view of Gains from Investment Securities shows it stood at $6.1 million in 2022, then plunged by 103.62% to -$220000.0 in 2024, then soared by 78.64% to -$47000.0 in 2025, then soared by 6512.77% to $3.0 million in 2026.
- Business Quant data shows XNCR's Gains from Investment Securities at $3.0 million in Q1 2026, -$47000.0 in Q4 2025, and $359000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Xencor | 953.38 Mn | 878.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.01 Mn |
| Mar 31, 2026 | 3.01 Mn |
| Dec 31, 2025 | -47,000.00 |
| Dec 31, 2025 | -47,000.00 |
| Sep 30, 2025 | 359,000.00 |
| Sep 30, 2025 | 359,000.00 |
| Jun 30, 2025 | 7.00 Mn |
| Jun 30, 2025 | 7.00 Mn |
| Jun 30, 2024 | -220,000.00 |
| Jun 30, 2024 | -220,000.00 |
| Mar 31, 2024 | 20.60 Mn |
| Mar 31, 2024 | 20.60 Mn |
| Dec 31, 2022 | 6.08 Mn |
| Dec 31, 2022 | 6.08 Mn |
| Sep 30, 2022 | 1.93 Mn |
| Sep 30, 2022 | 1.93 Mn |
| Jun 30, 2022 | 1.88 Mn |
| Jun 30, 2022 | 1.88 Mn |
| Mar 31, 2022 | 67,331.00 |
| Mar 31, 2022 | 67,331.00 |